These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 28287102

  • 1. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
    Kawiak A, Domachowska A, Jaworska A, Lojkowska E.
    Sci Rep; 2017 Mar 13; 7():43781. PubMed ID: 28287102
    [Abstract] [Full Text] [Related]

  • 2. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
    Fu Y, Li J, Lee AS.
    Cancer Res; 2007 Apr 15; 67(8):3734-40. PubMed ID: 17440086
    [Abstract] [Full Text] [Related]

  • 3. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).
    Zhou H, Zhang Y, Fu Y, Chan L, Lee AS.
    J Biol Chem; 2011 Jul 22; 286(29):25687-96. PubMed ID: 21622563
    [Abstract] [Full Text] [Related]

  • 4. Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.
    Viedma-Rodriguez R, Baiza-Gutman LA, García-Carrancá A, Moreno-Fierros L, Salamanca-Gómez F, Arenas-Aranda D.
    Int J Oncol; 2013 Dec 22; 43(6):1777-86. PubMed ID: 24100375
    [Abstract] [Full Text] [Related]

  • 5. Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation.
    Pujari R, Jose J, Bhavnani V, Kumar N, Shastry P, Pal JK.
    Int J Biochem Cell Biol; 2016 Aug 22; 77(Pt A):57-67. PubMed ID: 27262235
    [Abstract] [Full Text] [Related]

  • 6. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
    Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH.
    J Cell Biochem; 2008 Dec 15; 105(6):1461-71. PubMed ID: 18980240
    [Abstract] [Full Text] [Related]

  • 7. Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
    Kawiak A, Domachowska A, Lojkowska E.
    J Nat Prod; 2019 Apr 26; 82(4):878-885. PubMed ID: 30810041
    [Abstract] [Full Text] [Related]

  • 8. Bik subcellular localization in response to oxidative stress induced by chemotherapy, in Two different breast cancer cell lines and a Non-tumorigenic epithelial cell line.
    Trejo-Vargas A, Hernández-Mercado E, Ordóñez-Razo RM, Lazzarini R, Arenas-Aranda DJ, Gutiérrez-Ruiz MC, Königsberg M, Luna-López A.
    J Appl Toxicol; 2015 Nov 26; 35(11):1262-70. PubMed ID: 26059411
    [Abstract] [Full Text] [Related]

  • 9. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
    Tseng CC, Zhang P, Lee AS.
    Neoplasia; 2019 Aug 26; 21(8):837-848. PubMed ID: 31306849
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of mitogen-activated protein kinase signaling pathway sensitizes breast cancer cells to endoplasmic reticulum stress-induced apoptosis.
    Yang F, Tang XY, Liu H, Jiang ZW.
    Oncol Rep; 2016 Apr 26; 35(4):2113-20. PubMed ID: 26796921
    [Abstract] [Full Text] [Related]

  • 11. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
    Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, Shao L, Li A, Yang N, Han X, Pan B, Zhang Z, Sun L, Sun Y.
    Oncotarget; 2016 Dec 06; 7(49):81452-81462. PubMed ID: 27845892
    [Abstract] [Full Text] [Related]

  • 12. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.
    Wang J, Liu S, Yin Y, Li M, Wang B, Yang L, Jiang Y.
    Apoptosis; 2015 Mar 06; 20(3):399-409. PubMed ID: 25501496
    [Abstract] [Full Text] [Related]

  • 13. Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.
    Viedma-Rodríguez R, Ruiz Esparza-Garrido R, Baiza-Gutman LA, Velázquez-Flores MÁ, García-Carrancá A, Salamanca-Gómez F, Arenas-Aranda D.
    Tumour Biol; 2015 Sep 06; 36(9):6991-7005. PubMed ID: 25861752
    [Abstract] [Full Text] [Related]

  • 14. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
    Lee DH, Jung Jung Y, Koh D, Lim Y, Lee YH, Shin SY.
    Cancer Lett; 2016 Mar 01; 372(1):1-9. PubMed ID: 26742460
    [Abstract] [Full Text] [Related]

  • 15. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
    Pradubyat N, Sakunrangsit N, Mutirangura A, Ketchart W.
    Phytomedicine; 2020 Jan 01; 66():153133. PubMed ID: 31790893
    [Abstract] [Full Text] [Related]

  • 16. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
    Hur J, Bell DW, Dean KL, Coser KR, Hilario PC, Okimoto RA, Tobey EM, Smith SL, Isselbacher KJ, Shioda T.
    Cancer Res; 2006 Oct 15; 66(20):10153-61. PubMed ID: 17047080
    [Abstract] [Full Text] [Related]

  • 17. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
    Thasni KA, Rakesh S, Rojini G, Ratheeshkumar T, Srinivas G, Priya S.
    Ann Oncol; 2008 Apr 15; 19(4):696-705. PubMed ID: 18187487
    [Abstract] [Full Text] [Related]

  • 18. Correlation of the protein expression of GRP78 and BIK/NBK with prognostic markers in patients with breast cancer and neoadjuvant chemotherapy.
    López-Muñoz E, Corres-Molina M, García-Hernández N.
    J Obstet Gynaecol; 2020 Apr 15; 40(3):419-426. PubMed ID: 31635499
    [Abstract] [Full Text] [Related]

  • 19. Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.
    Zhang XQ, Yang CY, Rao XF, Xiong JP.
    Eur J Gynaecol Oncol; 2016 Apr 15; 37(1):30-5. PubMed ID: 27048106
    [Abstract] [Full Text] [Related]

  • 20. IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78.
    Li C, Harada A, Oh Y.
    Cancer Lett; 2012 Dec 28; 325(2):200-6. PubMed ID: 22801219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.